Trifluridine/Tipiracil (TAS‐102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

BACKGROUND. TAS‐102 is indicated for patients with metastatic colorectal cancer (mCRC) previously treated with, or not considered candidates for, available therapies. Given the complete inefficacy in half of patients, the lack of predictive factors, the palliative setting, and the financial and clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Cremolini, Chiara, Rossini, Daniele, Martinelli, Erika, Pietrantonio, Filippo, Lonardi, Sara, Noventa, Silvia, Tamburini, Emiliano, Frassineti, Giovanni Luca, Mosconi, Stefania, Nichetti, Federico, Murgioni, Sabina, Troiani, Teresa, Borelli, Beatrice, Zucchelli, Gemma, Dal Maso, Alessandro, Sforza, Vincenzo, Masi, Gianluca, Antoniotti, Carlotta, Di Bartolomeo, Maria, Miceli, Rosalba, Ciardiello, Fortunato, Falcone, Alfredo
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2018
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263124/
https://ncbi.nlm.nih.gov/pubmed/29739893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0573
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados